AgeX

$1.84
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$0.10 (-5.15%) Today

$0.00 (0.00%) As of 12:34 AM UTC after-hours

Why Robinhood?

You can buy or sell AgeX and other stocks, options, and ETFs commission-free!

About AGE

AgeX Therapeutics, Inc. operates as a biotechnology company. The firm focuses on the development and commercialization of novel therapeutics targeting human aging and degenerative diseases. Its technology platforms include PureStem, UniverCyte, iTR and HyStem. The company was founded by Michael D. West in 2017 and is headquartered in Alameda, CA. The listed name for AGE is AgeX Therapeutics, Inc.

CEO

Michael D. West

Employees

Headquarters

Alameda, California

Founded

2017

Market Cap

62.20M

Price-Earnings Ratio

—

Dividend Yield

—

Average Volume

230.11K

High Today

$1.97

Low Today

$1.76

Open Price

$1.97

Volume

363.77K

52 Week High

$3.93

52 Week Low

$0.666

Collections

AGE Earnings

-$0.28

-$0.19

-$0.09

$0.00

Q2 FY19

Q3 FY19

Q4 FY19

Q1 FY20

Q2 FY20

Q3 FY20

Q4 FY20

Estimated

— per share

Actual

Expected Mar 30, After Hours